Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01672632 · ClinicalTrials.gov registry record · NA

Fat Cell Size and Overfeeding and Etopic Study

A NA study of Overeating, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01672632: Completed NA study of Overeating, sponsored by Pennington Biomedical Research Center.

NCT01672632 is a NA study of Overeating that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 40 participants, below the 65-participant average among 3 other Overeating trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01672632, a NA study of Overeating, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

It has been shown that large fat cells are associated with more risks for insulin resistance and more cardiovascular risk factors such as high cholesterol or triglycerides.

Primary Outcome

This study will investigate how fat cell size (independent of total fat mass) affects metabolic outcomes of overfeeding, including changes in fat deposition, insulin sensitivity and muscle oxidative capacity. It has been shown that large fat cells relative to fat mass are associated with higher risks for insulin resistance and type 2 diabetes.

Conditions Studied

Interventions

  • OTHER Overfeeding

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2008-05
Est. Completion 2020-12
Phase NA

What the finished NCT01672632 record still lists

NCT01672632 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 65-participant average among 3 other Overeating trials with a reported enrollment target (38% lower).

The record links to 1 condition, with Overeating appearing as the primary indexed condition, and to 1 intervention - of which Overfeeding is the first listed.

NCT01672632 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT01672632 about?

NCT01672632 is a clinical study titled "Fat Cell Size and Overfeeding and Etopic Study". It has been shown that large fat cells are associated with more risks for insulin resistance and more cardiovascular risk factors such as high cholesterol or triglycerides.

What is the current status of trial NCT01672632?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2008-05. Estimated completion is 2020-12.

What conditions does trial NCT01672632 study?

This clinical trial studies the following conditions: Overeating.

What interventions are being tested in trial NCT01672632?

The interventions under investigation include: Overfeeding (OTHER).

Who is sponsoring clinical trial NCT01672632?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01672632 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overeating

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01672632, the US trial registry maintained by the National Library of Medicine. NCT01672632 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.